memantine has been researched along with Disorder, Borderline Personality in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Memantine-HCl is a voltage-dependent N-methyl-D-aspartate (NMDA) receptor 'channel blocker' that selectively blocks pathological glutamate overactivity." | 6.87 | Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial. ( Arnold, A; Cheng, J; Gavrilidis, E; Grigg, J; Gurvich, C; Hudaib, AR; Kulkarni, J; Tan, R; Thomas, N, 2018) |
| "Memantine-HCl is a voltage-dependent N-methyl-D-aspartate (NMDA) receptor 'channel blocker' that selectively blocks pathological glutamate overactivity." | 2.87 | Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial. ( Arnold, A; Cheng, J; Gavrilidis, E; Grigg, J; Gurvich, C; Hudaib, AR; Kulkarni, J; Tan, R; Thomas, N, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulkarni, J | 1 |
| Thomas, N | 1 |
| Hudaib, AR | 1 |
| Gavrilidis, E | 1 |
| Grigg, J | 1 |
| Tan, R | 1 |
| Cheng, J | 1 |
| Arnold, A | 1 |
| Gurvich, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised Double-blind Placebo Controlled Investigation of the Efficacy of a Novel Drug as an Adjunct in Patients With Borderline Personality Disorder[NCT02097706] | Phase 2 | 150 participants (Anticipated) | Interventional | 2015-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for memantine and Disorder, Borderline Personality
| Article | Year |
|---|---|
Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.
Topics: Adolescent; Adult; Aged; Australia; Borderline Personality Disorder; Double-Blind Method; Excitatory | 2018 |